Ben’s extensive experience includes serving as lead counsel on an array of matters, such as licensing deals, asset purchases, commercial transactions, manufacturing and supply agreements, wholesaler and distributor agreements, commercial launches, pricing, rebates and discounts, Sunshine Act/Open Payments reporting, promotional policies and practices, compliance programs, and internal investigations.
Ben also provides counsel to life sciences companies on a variety of laws and regulations administered and enforced by federal authorities, such as FDA, FTC, OIG, CMS, and DOJ, as well as state authorities, such as attorneys general, boards of pharmacy, departments of health, and others. Ben assists companies with development and administration of effective compliance programs, particularly with regard to applicable laws, regulations, agency guidance, and industry codes and standards, e.g., PhRMA Code, AdvaMed Code.
Prior to joining the firm, Ben spent more than a decade as in-house counsel with both privately-held and publicly-traded pharmaceutical and life sciences companies in the Triangle. Most recently, Ben served as the General Counsel and Chief Compliance Officer for RedHill Biopharma, a commercial-stage pharmaceutical company.
When Ben is not practicing law, he is an avid runner and enjoys traveling and visiting the Crystal Coast with his wife, Meghan, and sons, Jack and Graham.